Biology Reference
In-Depth Information
Boullier S, Dadaglio G, Lafeuillade A, Debord T, Gougeon ML. 1997. V delta 1 T cells expanded
in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-
alpha and IFN-gamma production but are not selected in lymph nodes. J Immunol 159: 3629±
3637.
Boullier S, Poquet Y, Halary F, Bonneville M, Fournie JJ, Gougeon ML. 1998. Phosphoantigen
activation induces surface translocation of intracellular CD94/NKG2A class I receptor on
CD94-peripheral Vgamma9 Vdelta2 T cells but not on CD94-thymic or mature gammadelta T
cell clones. Eur J Immunol 28: 3399±3410.
Boullier S, Poquet Y, Debord T, Fournie JJ, Gougeon ML. 1999. Regulation by cytokines (IL-12,
IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoanti-
gens in responder and anergic HIV-infected persons. Eur J Immunol 29: 90±99.
Braakman E, Sturm E, Vijverberg K, van Krimpen BA, Gratama JW, Bolhuis RL. 1991. Expres-
sion of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural
killer cells. Int Immunol 3: 691±697.
Brenner MB, McLean J, Dialynas DP, Strominger JL, Smith JA, Owen FL, Seidman JG, Ip S,
Rosen F, Krangel MS. 1986. Identi®cation of a putative second T-cell receptor. Nature 322:
145±149.
Brenner MB, Strominger JL, Krangel MS. 1988. The gamma delta T cell receptor. Adv Immunol 43:
133±192.
Bukowski JF, Morita CT, Brenner MB. 1994. Recognition and destruction of virus-infected cells by
human gamma delta CTL. J Immunol 153: 5133±5140.
Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H. 1995. V gamma 2V delta 2
TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene
transfer. J Immunol 154: 998±1006.
Bukowski JF, Morita CT, Brenner MB. 1999. Human gamma delta T cells recognize alkylamines
derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11:
57±65.
Carding SR. 1990. A role for gamma/delta T cells in the primary immune response to in¯uenza
virus. Res Immunol 141: 603±606.
Carding SR, Allan W, Kyes S, Hayday A, Bottomly K, Doherty PC. 1990a. Late dominance of the
in¯ammatory process in murine in¯uenza by gamma/delta T cells. J Exp Med 172: 1225±
1231.
Carding SR, McNamara JG, Pan M, Bottomly K. 1990b. Characterization of gamma/delta T cell
clones isolated from human fetal liver and thymus. Eur J Immunol 20: 1327±1335.
Carena I, Shamshiev A, Donda A, Colonna M, Libero GD. 1997. Major histocompatibility com-
plex class I molecules modulate activation threshold and early signaling of T cell antigen re-
ceptor-gamma/delta stimulated by nonpeptidic ligands. J Exp Med 186: 1769±1774.
Casorati G, De Libero G, Lanzavecchia A, Migone N. 1989. Molecular analysis of human gamma/
delta clones from thymus and peripheral blood. J Exp Med 170: 1521±1535.
Chervenak KA, Lederman MM, Boom WH. 1997. Bacterial antigen activation of Vdelta1 and
Vdelta2 gammadelta T cells of persons infected with human immunode®ciency virus type 1. J
Infect Dis 175: 429±433.
Chia WK, Freedman J, Li X, Salit I, Kardish M, Read SE. 1995. Programmed cell death induced
by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte
activity in advanced HIV type 1 infection. AIDS Res Hum Retroviruses 11: 249±256.
Chien YH, Davis MM. 1993. How alpha beta T-cell receptors `see' peptide/MHC complexes. Im-
munol Today 14: 597±602.
Chien YH, Iwashima M, Kaplan KB, Elliott JF, Davis MM. 1987. A new T-cell receptor gene
located within the alpha locus and expressed early in T-cell di¨erentiation. Nature 327: 677±
682.
